| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Agios Pharmaceuticals, Inc. (AGIO) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 149.1K | $5.23M | - | |
| Other | 67.7K | $2.38M | - | |
| CFO | 40.3K | $1.42M | - | |
| Other | 34.6K | $1.22M | - | |
| Dir | 17.8K | $624.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 25, 2018 | Hoerter Steven L. | Chief Commercial Officer | Sale+OE | 2,050 | $84.58 | $173,389.00 | -100% | |
| Jul 10, 2018 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 2,000 | $86.76 | $173,512.00 | -43.0% | |
| Jul 9, 2018 | Alenson Carman65 | Principal Accounting Officer | Sale+OE | 272 | $84.94 | $23,103.68 | -100% | |
| Jul 5, 2018 | Biller Scott | Chief Scientific Officer | Sale+OE | 3,000 | $83.50 | $250,503.00 | -2.5% | |
| Jun 22, 2018 | Hoerter Steven L. | Chief Commercial Officer | Sale+OE | 2,050 | $97.58 | $200,039.00 | -100% | |
| Jun 14, 2018 | Foster-Cheek Kaye I | Director | Sale+OE | 9,000 | $93.55 | $841,926.32 | -38.7% | |
| Jun 12, 2018 | Bowden Christopher82 | Chief Medical Officer | Sale+OE | 2,000 | $92.89 | $185,786.00 | -50.5% | |
| Jun 5, 2018 | Biller Scott | Chief Scientific Officer | Sale+OE | 3,000 | $93.37 | $280,100.75 | -1.7% | |
| Jun 1, 2018 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 13,000 | $95.35 | $1,239,607.70 | -46.6% | |
| May 30, 2018 | Schenkein David P59 | Chief Executive Officer | Sale+OE | 45,626 | $90.07 | $4,109,533.82 | -100% |